FFCP PHASE1:Hg19::chr15:60695090..60695093,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=302 | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_protein_coding | |||
|HGNC=537 | |||
|TSSclassifier=strong | |||
|UniProt= | |||
|association_with_transcript=-8bp_to_ENST00000557904_5end | |||
|coexpression_cluster_id=C55 | |||
|description=CAGE_peak_19_at_ANXA2_5end | |||
|id=chr15:60695090..60695093,- | |||
|ontology_enrichment_celltype=CL:0000181!1.10e-14!12;CL:0000417!1.10e-14!12;CL:0000668!1.10e-14!12;CL:0000414!1.10e-14!12;CL:0000412!1.10e-14!12;CL:0000182!1.10e-14!12;CL:0000223!3.95e-08!59 | |||
|ontology_enrichment_celltype_v019=CL:0000182;2.84e-44;12 | |||
|ontology_enrichment_celltype_v019_2=CL:0000182,2.84e-44,12;CL:0000223,1.09e-09,58 | |||
|ontology_enrichment_development_v019=UBERON:0004161;1.07e-27;11!UBERON:0009497;1.39e-23;13!UBERON:0001041;1.09e-10;30!UBERON:0003104;3.73e-10;31!CL:0000223;2.19e-07;58 | |||
|ontology_enrichment_disease=DOID:3112!1.07e-11!1;DOID:299!2.15e-10!25 | |||
|ontology_enrichment_disease_v019=DOID:3493;9.07e-18;2!DOID:7;9.06e-09;39 | |||
|ontology_enrichment_disease_v019_2=DOID:3493,1.07e-17,2;DOID:7,2.08e-08,39;DOID:305,3.00e-08,106 | |||
|ontology_enrichment_uberon=UBERON:0001831!5.05e-12!1;UBERON:0001567!5.05e-12!1;UBERON:0008801!5.05e-12!1;UBERON:0003929!1.24e-11!54;UBERON:0009497!1.17e-10!25;UBERON:0000015!1.17e-10!25;UBERON:0002423!1.17e-10!25;UBERON:0006235!1.17e-10!25;UBERON:0004161!1.17e-10!25;UBERON:0002107!2.39e-09!19;UBERON:0006925!2.39e-09!19;UBERON:0008836!2.39e-09!19;UBERON:0002365!1.32e-08!31;UBERON:0002330!1.32e-08!31;UBERON:0002530!3.43e-08!59;UBERON:0000949!4.14e-08!45;UBERON:0008835!4.28e-08!22;UBERON:0003894!4.28e-08!22;UBERON:0001007!6.34e-08!155;UBERON:0001555!6.34e-08!155;UBERON:0007026!6.34e-08!155;UBERON:0009854!9.50e-08!23;UBERON:0002368!1.47e-07!35;UBERON:0005911!2.45e-07!82;UBERON:0007499!3.86e-07!25;UBERON:0004119!4.03e-07!169;UBERON:0000925!4.03e-07!169;UBERON:0006595!4.03e-07!169;UBERON:0005057!7.20e-07!26;UBERON:0009856!7.20e-07!26;UBERON:0000077!9.70e-07!130 | |||
|ontology_enrichment_uberon_v019=UBERON:0002107;2.86e-28;19!UBERON:0006925;2.86e-28;19!UBERON:0002423;1.15e-21;25!UBERON:0002365;1.12e-16;31!UBERON:0002330;1.12e-16;31!UBERON:0002368;6.36e-16;33!UBERON:0000949;2.70e-12;43!UBERON:0002530;1.48e-08;57!UBERON:0002417;2.78e-07;58!UBERON:0000916;2.78e-07;58 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002107,2.86e-28,19;UBERON:0006925,2.86e-28,19;UBERON:0008836,2.86e-28,19;UBERON:0008835,1.61e-24,22;UBERON:0003894,1.61e-24,22;UBERON:0009854,1.74e-23,23;UBERON:0007499,1.15e-21,25;UBERON:0009497,1.15e-21,25;UBERON:0000015,1.15e-21,25;UBERON:0002423,1.15e-21,25;UBERON:0006235,1.15e-21,25;UBERON:0004161,1.15e-21,25;UBERON:0009856,7.34e-21,26;UBERON:0002365,1.31e-17,31;UBERON:0002330,1.31e-17,31;UBERON:0002368,1.13e-15,35;UBERON:0000949,2.51e-12,45;UBERON:0003929,2.28e-10,54;UBERON:0005172,2.28e-10,54;UBERON:0005173,2.28e-10,54;UBERON:0002530,1.55e-09,59;UBERON:0002417,2.20e-09,60;UBERON:0000916,2.20e-09,60;UBERON:0005911,5.36e-07,82 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.438977620880838,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.26755034821831,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.241718899183244,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.309123034943167,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.202910376962704,0,0,0,0,0,0,0,0,0,0,0,0,0,0.376575203107117,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.68426486367398,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.141353071433941,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.213452994739353,0,0,0,0,0,0,0,0,0,0.101998217636322,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.49688046383725,1.7307330260045,2.42652757875066,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.107410557042488,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.163771917510097,0,0,0,0,0,0,0.548257766857182,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.34109717480496,0,0,0,0,0,0,0,0,0,0,0.0771741581079447,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0898252021065869,0,0,0,0,0,0 | |||
|short_description=p19@ANXA2 | |||
}} |
Revision as of 23:54, 11 January 2014
Short description: | p19@ANXA2 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_19_at_ANXA2_5end |
Coexpression cluster: | C55_hepatocellular_Intestinal_liver_Prostate_fibrosarcoma_Hepatocyte_hepatoblastoma |
Association with transcript: | -8bp_to_ENST00000557904_5end |
EntrezGene: | ANXA2 |
HGNC: | 537 |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
hepatocyte | 2.84e-44 | 12 |
endodermal cell | 1.09e-09 | 58 |
Ontology term | p-value | n |
---|---|---|
liver | 2.86e-28 | 19 |
digestive gland | 2.86e-28 | 19 |
liver bud | 2.86e-28 | 19 |
hepatic diverticulum | 1.61e-24 | 22 |
liver primordium | 1.61e-24 | 22 |
digestive tract diverticulum | 1.74e-23 | 23 |
epithelial sac | 1.15e-21 | 25 |
epithelium of foregut-midgut junction | 1.15e-21 | 25 |
anatomical boundary | 1.15e-21 | 25 |
hepatobiliary system | 1.15e-21 | 25 |
foregut-midgut junction | 1.15e-21 | 25 |
septum transversum | 1.15e-21 | 25 |
sac | 7.34e-21 | 26 |
exocrine gland | 1.31e-17 | 31 |
exocrine system | 1.31e-17 | 31 |
endocrine gland | 1.13e-15 | 35 |
endocrine system | 2.51e-12 | 45 |
gut epithelium | 2.28e-10 | 54 |
abdomen element | 2.28e-10 | 54 |
abdominal segment element | 2.28e-10 | 54 |
gland | 1.55e-09 | 59 |
abdominal segment of trunk | 2.20e-09 | 60 |
abdomen | 2.20e-09 | 60 |
endo-epithelium | 5.36e-07 | 82 |
Ontology term | p-value | n |
---|---|---|
signet ring cell adenocarcinoma | 1.07e-17 | 2 |
disease of anatomical entity | 2.08e-08 | 39 |
carcinoma | 3.00e-08 | 106 |